Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Novel Tools for Determining Risk of Respiratory Complications Following Hematopoietic Stem Cell Transplant

NCT05766332 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05766332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05766332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Novel Tools for Determining Risk of Respiratory Complications Following Hematopoietic Stem Cell Transplant
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
August 2, 2021
Completion date
November 17, 2023
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid system neoplasm, malignant solid neoplasm